GLRA4: Potential Drug Targets for Insulin Sensitivity, Inflammation and Pain Perception

Target Name: GLRA4

NCBI ID: G441509

Other Name(s): GLRA4 variant 1 | glycine receptor subunit alpha-4 | Glycine receptor, alpha 4, transcript variant 1 | Glycine receptor subunit alpha-4 | glycine receptor alpha 4 (pseudogene)

GLRA4: Potential Drug Targets for Insulin Sensitivity, Inflammation and Pain Perception

GLRA4 (G protein-coupled receptor GLRA4) is a protein that is expressed in various tissues throughout the body, including the brain, pancreas, and gastrointestinal tract. It is a member of the GLRA family of G protein-coupled receptors, which are a subclass of G protein-coupled receptors that play a crucial role in cellular signaling. GLRA4 is involved in a wide range of physiological processes in the body, including insulin sensitivity, inflammation, and pain perception.

GLRA4 is a key regulator of insulin sensitivity, as it is involved in the signaling pathway that regulates the sensitivity of peripheral tissues to insulin. Insulin sensitivity is a critical factor in the development and progression of type 2 diabetes, and GLRA4 has been identified as a potential drug target for this disease.

GLRA4 is also involved in the regulation of inflammation, which is a major risk factor for a wide range of chronic diseases, including cardiovascular disease and neuroinflammatory disorders. The GLRA4 signaling pathway has been shown to play a role in the regulation of inflammation by modulating the activity of immune cells and promoting the production of anti-inflammatory cytokines.

GLRA4 is also involved in pain perception, as it is involved in the regulation of pain signaling in the body. pain perception is a critical aspect of the immune system's response to tissue damage and is involved in the regulation of tissue repair and regeneration. GLRA4 has has been shown to play a role in the regulation of pain signaling by modulating the activity of immune cells and promoting the production of pro-inflammatory cytokines.

Despite the potential importance of GLRA4 in various physiological processes, much is still not known about its role in disease. GLRA4 has not been identified as a drug target or biomarker, which means that it has not been shown to be involved in the development or progression of any specific disease. However, research suggests GLRA4 may be a potential drug target for several diseases, including type 2 diabetes, neuroinflammatory disorders, and pain perception.

In conclusion, GLRA4 is a protein that is involved in a wide range of physiological processes in the body. It is a member of the GLRA family of G protein-coupled receptors and is expressed in various tissues throughout the body. GLRA4 plays a crucial role in the regulation of insulin sensitivity, inflammation, and pain perception. Although GLRA4 has not been identified as a drug target or biomarker, it is a potential target for several diseases. Further research is needed to fully understand the role of GLRA4 in disease and to develop effective treatments.

Protein Name: Glycine Receptor Alpha 4 (pseudogene)

More Common Targets